Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ATAD5 functions as a regulatory platform for Ub-PCNA deubiquitination. | Proc Natl Acad Sci U S A | 2024 | 39145935 | PubTator, text mining | PubMed |
| Esculin alleviates lipopolysaccharide (LPS)-induced pneumonia by regulating the USP7/MAPK14 axis. | J Appl Toxicol | 2024 | 39142713 | PubTator, text mining | PubMed |
| Ubiquitin's Conformational Heterogeneity as Discerned by Nuclear Magnetic Resonance Spectroscopy. | Chembiochem | 2024 | 39140844 | PubTator, text mining | PubMed |
| Molecular signatures in Mendelian neurodevelopment: a focus on ubiquitination driven DNA methylation aberrations. | Front Mol Neurosci | 2024 | 39135741 | PubTator, text mining | PubMed |
| Discovery of pyrrolo[2,3-d]pyrimidin-4-one derivative YCH3124 as a potent USP7 inhibitor for cancer therapy. | Eur J Med Chem | 2024 | 39133975 | PubTator, text mining | PubMed |
| Integrating Mendelian randomization and single-cell RNA sequencing to identify therapeutic targets of baicalin for type 2 diabetes mellitus. | Front Pharmacol | 2024 | 39130628 | PubTator, text mining | PubMed |
| USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion. | J Biol Chem | 2024 | 39128723 | PubTator, text mining | PubMed |
| USP7/NOTCH1: A potential therapeutic mechanism for cardiac diseases. | Int J Cardiol | 2024 | 39117072 | PubTator, text mining | PubMed |
| Exosomal circ-0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7/NRF2 axis. | Clin Transl Med | 2024 | 39107958 | PubTator, text mining | PubMed |
| USP7-stabilised HIPK2 promotes high glucose-induced endothelial cell dysfunctions to accelerate diabetic foot ulcers. | Arch Physiol Biochem | 2024 | 39066661 | PubTator, text mining | PubMed |
| Identification of mechanism of the oncogenic role of FGFR1 in papillary thyroid carcinoma. | Eur J Histochem | 2024 | 39037153 | PubTator, text mining | PubMed |
| Discovery of a Highly Potent, Selective and Efficacious USP7 Degrader for the Treatment of Acute Lymphoblastic Leukemia. | J Med Chem | 2024 | 39028938 | PubTator, text mining | PubMed |
| Identification of potential inhibitors for drug resistance in acute lymphoblastic leukemia through differentially expressed gene analysis and in silico screening. | Anal Biochem | 2024 | 39025197 | PubTator, text mining | PubMed |
| PRMT1 promotes Warburg effect by regulating the PKM2/PKM1 ratio in non-small cell lung cancer. | Cell Death Dis | 2024 | 39009589 | PubTator, text mining | PubMed |
| An insight into the roles of ubiquitin-specific proteases in plants: development and growth, morphogenesis, and stress response. | Front Plant Sci | 2024 | 38993940 | PubTator, text mining | PubMed |
| Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53. | Drug Des Devel Ther | 2024 | 38974119 | PubTator, text mining | PubMed |
| USP7 upregulated by TGF-β1 promotes ferroptosis via inhibiting LATS1-YAP axis in sepsis-induced acute lung injury. | iScience | 2024 | 38966570 | PubTator, text mining | PubMed |
| The phosphorylation-deubiquitination positive feedback loop of the CHK2-USP7 axis stabilizes p53 under oxidative stress. | Cell Rep | 2024 | 38879877 | PubTator, text mining | PubMed |
| USP7 promotes IgA class switching through stabilizing RUNX3 for germline transcription activation. | Cell Rep | 2024 | 38795349 | PubTator, text mining | PubMed |
| Molecular characterization, clinical value, and cancer-immune interactions of genes related to disulfidptosis and ferroptosis in colorectal cancer. | Discov Oncol | 2024 | 38787520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=17